Prof Khachigian is a vascular cell and molecular biologist elucidating fundamental transcriptional mechanisms that lead to the inappropriate expression of harmful genes in vascular cells. Exploiting this science, I am also a “translational” researcher who has pioneered the development of novel strategies targeting key regulatory genes to combat angiogenesis-dependent cancers, and potentially other common vascular disorders such as post-angioplasty restenosis, bypass graft stenosis, ocular neovas ....Prof Khachigian is a vascular cell and molecular biologist elucidating fundamental transcriptional mechanisms that lead to the inappropriate expression of harmful genes in vascular cells. Exploiting this science, I am also a “translational” researcher who has pioneered the development of novel strategies targeting key regulatory genes to combat angiogenesis-dependent cancers, and potentially other common vascular disorders such as post-angioplasty restenosis, bypass graft stenosis, ocular neovascularisation and rheumatoid arthritis.Read moreRead less
Fellowship Application, Ed Stanley: Pluripotent Stem Cells & Medical Research
Funder
National Health and Medical Research Council
Funding Amount
$638,517.00
Summary
Human Pluripotent Stem Cells are immortal cells that have the ability to turn into any of the cell types found in the body. This means that it is now possible to generate a variety of human cell types in the laboratory, to study how they work, and to find out what goes wrong in different diseases. In this context, the overall aim of my research is to develop pluripotent stem cells for the study of human disease and generate tools that will enable others to use these cells in their own research.
Identifying The Genetic And Environmental Causes Of Congenital Malformation
Funder
National Health and Medical Research Council
Funding Amount
$774,540.00
Summary
Birth defects are common, devastating and costly to families and to society. The cause is unknown in 80% of cases. This research is helping families by finding the gene mutations that cause birth defects. Gene discoveries, in some cases, will highlight environmental factors that are important for normal embryo formation, such as oxygen levels and dietary components. By identifying gene and environmental factors associated with causing birth defects, we hope to ameliorate or prevent many cases.
The goal of this research is to improve outcomes for people at risk of becoming blind or visually impaired. The focus is on those who require a corneal transplant, or who suffer from inflammatory eye disease or painful disease of the ocular surface, on neonates with retinopathy of prematurity, or those with the eye disease, keratoconus. We will investigate new treatment options for eye diseases and will examine the evidence for the success of surgical and other therapeutic interventions.
Understanding The Kidney: From Morphogenesis To Regeneration
Funder
National Health and Medical Research Council
Funding Amount
$850,346.00
Summary
In Australia, 11.3% of deaths are associated with chronic kidney disease with >$1 billion per annum spent on treating this condition. Kidney function throughout life depends upon what happened during your foetal development as all the functional units of the kidney are made prior to birth. In this project, we will use our understanding of normal kidney development to develop new regenerative approaches to the treatment of this condition.
Gene-environment Interactions, Experience-dependent Plasticity And Pathogenic Mechanisms In Mouse Models Of Cognitive And Affective Disorders. Mental And Physical Activity As Modulators Of Brain And Behaviour In Healthy And Diseased States.
Funder
National Health and Medical Research Council
Funding Amount
$250,805.00
Summary
Our aim is to understand how genes and environment combine to affect susceptibility to various brain disorders. We are using specific models involving human gene mutations associated with diseases, and manipulating environmental factors such as mental and physical activity. We are focused on neurological and psychiatric disorders, including Huntington’s disease, depression and schizophrenia. These efforts to understand brain diseases will facilitate development of therapeutic approaches.
Cancers arise as a result of the impairment of critical cellular processes following the mutation of important regulatory genes. I am a molecular biologist and I study how the proteins of the Bcl-2 family regulate apoptosis, a process of cell death essential to maintain homeostasis in multicellular organisms, with the aim of designing drugs to kill cancer cells selectively. I am also interested in discovering new genes involved in the development of cancer using new genomics technology.
Epilepsy is a very common and serious brain disorder. Epilepsy often includes other disabilities, reduction in quality of life and is associated with increased risk of early death. 30% of people with epilepsy are unable to gain control of their seizures with currently available medications. The genetic causes of the large majority of epilepsy cases have not yet been found. This project aims to identify new genetic causes of epilepsy and its related disorders.
Nigel G Laing, NH&MRC Principal Research Fellowship: Neurogenetics – Gene Discovery, Pathobiology, Novel Therapeutics, Novel Diagnostics And Translation.
Funder
National Health and Medical Research Council
Funding Amount
$880,454.00
Summary
My Fellowship will expand my work identifying diseases genes for genetic muscle and nerve diseases by using new technologies that allow discovery of human disease genes which could not be found before. In addition, since we now have proof from mouse studies that heart actin is a target for therapy for the group of diseases that we discovered caused by mutations in the muscle actin protein, we shall take further steps towards making this therapy a reality for patients.
I aim to decipher the role of heritable, genetic DNA variation in human neurological disease. I will use next generation genomics technologies together with sophisticated cellular models to address the important questions of the biology of epilepsy and intellectual disability in particular. I aim to develop a treatment for a specific type of epilepsy, which affects only girls from the age of 6 months. My ultimate goal is to improve the life of the patients and their relatives.